2 ms·
Quality. The problem tends to come down to human trials. Very few countries have a combination of the quality of medicine, the proper oversight, and a large eno
by lloyd-christmas 11y ago
Quality. The problem tends to come down to human trials. Very few countries have a combination of the quality of medicine, the proper oversight, and a large enough population to actually make the trials worthwhile. China/India simply don't have the same quality control as that of US/Europe/Japan.
Beyond that, humans aren't all equal. Drug trials in the US make an effort to represent the general US demographics within their studies (which is also representative of Europe). Clinical trials of a 100% Indian population have questionable relevance any other country, and will likely require the entire study to be redone with a population-representative sample.
- option_greek 11y agoAre there any drugs that work well with one populace but are harmful to another ?
- lloyd-christmas 11y agoYep. I'd have to dig for examples, but many cancer drugs have different efficacies on differing ethnic populations. My father researches genetic markers vs. success rates in different treatments for the same types of cancer. He sees it constantly (Dinner conversation; his big data vs my big data). It's easy enough to assume they do given the different rates of diseases among ethnic groups. From my viewpoint, I would be more shocked if they did actually have the same efficacy.